These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 11978814)

  • 1. Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition.
    Savage MJ; Lin YG; Ciallella JR; Flood DG; Scott RW
    J Neurosci; 2002 May; 22(9):3376-85. PubMed ID: 11978814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice.
    Puig B; Gómez-Isla T; Ribé E; Cuadrado M; Torrejón-Escribano B; Dalfó E; Ferrer I
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):491-502. PubMed ID: 15488025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice.
    Ferrer I
    Neurotox Res; 2004; 6(6):469-75. PubMed ID: 15658002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
    Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
    Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss.
    Takeuchi A; Irizarry MC; Duff K; Saido TC; Hsiao Ashe K; Hasegawa M; Mann DM; Hyman BT; Iwatsubo T
    Am J Pathol; 2000 Jul; 157(1):331-9. PubMed ID: 10880403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JNK activation is associated with intracellular beta-amyloid accumulation.
    Shoji M; Iwakami N; Takeuchi S; Waragai M; Suzuki M; Kanazawa I; Lippa CF; Ono S; Okazawa H
    Brain Res Mol Brain Res; 2000 Dec; 85(1-2):221-33. PubMed ID: 11146125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
    Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
    J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.
    Ma QL; Yang F; Rosario ER; Ubeda OJ; Beech W; Gant DJ; Chen PP; Hudspeth B; Chen C; Zhao Y; Vinters HV; Frautschy SA; Cole GM
    J Neurosci; 2009 Jul; 29(28):9078-89. PubMed ID: 19605645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.
    Siman R; Reaume AG; Savage MJ; Trusko S; Lin YG; Scott RW; Flood DG
    J Neurosci; 2000 Dec; 20(23):8717-26. PubMed ID: 11102478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.
    Zhu X; Raina AK; Rottkamp CA; Aliev G; Perry G; Boux H; Smith MA
    J Neurochem; 2001 Jan; 76(2):435-41. PubMed ID: 11208906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway.
    Li Y; Liu L; Barger SW; Griffin WS
    J Neurosci; 2003 Mar; 23(5):1605-11. PubMed ID: 12629164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of mitogen-activated protein kinase pathways in Alzheimer's disease.
    Zhu X; Lee HG; Raina AK; Perry G; Smith MA
    Neurosignals; 2002; 11(5):270-81. PubMed ID: 12566928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase.
    Mudher A; Chapman S; Richardson J; Asuni A; Gibb G; Pollard C; Killick R; Iqbal T; Raymond L; Varndell I; Sheppard P; Makoff A; Gower E; Soden PE; Lewis P; Murphy M; Golde TE; Rupniak HT; Anderton BH; Lovestone S
    J Neurosci; 2001 Jul; 21(14):4987-95. PubMed ID: 11438574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β2 adrenergic receptor, protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer disease models.
    Wang D; Fu Q; Zhou Y; Xu B; Shi Q; Igwe B; Matt L; Hell JW; Wisely EV; Oddo S; Xiang YK
    J Biol Chem; 2013 Apr; 288(15):10298-307. PubMed ID: 23430246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction.
    Flood DG; Reaume AG; Dorfman KS; Lin YG; Lang DM; Trusko SP; Savage MJ; Annaert WG; De Strooper B; Siman R; Scott RW
    Neurobiol Aging; 2002; 23(3):335-48. PubMed ID: 11959395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
    Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S
    Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1.
    Boutajangout A; Authelet M; Blanchard V; Touchet N; Tremp G; Pradier L; Brion JP
    Neurobiol Dis; 2004 Feb; 15(1):47-60. PubMed ID: 14751770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.